- ￥1250 - 5500
- MedChemExpress(MCE)
- 美国
- HY-50713
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
478963-79-0
- 规格：
10 mM * 1 mL/5 mg/10 mg/50 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥2200.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥1250.0 |
| 规格： | 10 mg | 产品价格： | ￥2000.0 |
| 规格： | 50 mg | 产品价格： | ￥5500.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Calcium-Sensing Receptor Antagonists I
CAS No. : 478963-79-0
MCE 国际站：Calcium-Sensing Receptor Antagonists I
产品活性：Calcium-Sensing Receptor Antagonists I是钙离子敏感的甲状旁腺素受体拮抗剂。Calcium-Sensing Receptor Antagonists I 是一种点击化学试剂。它含有 Alkyne 基团，可以和含有 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。
研究领域：GPCR/G Protein
作用靶点：CaSR
相关产品：Covalent Screening Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Covalent Screening Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | NPS-2143 | Etelcalcetide hydrochloride | Gadolinium chloride | Cinacalcet | Evocalcet | Calhex 231 hydrochloride | Tecalcet Hydrochloride | γ-L-Glutamyl-L-alanine | NPS 2390 | Ligustroflavone | Upacicalcet sodium | SB-423562 | Calindol hydrochloride | GSK3004774 | Strontium Ranelate | AC-265347 | CaSR antagonist-1 | Gamma-Glu-Abu | SB-423557
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identification of Adipokine Receptor Agonists and Turning Them to Antagonists
selectivity of 1,000 in cellular assays. The design process of ObR antagonists included shortening of the peptide length and incorporating additional nonnatural residues. Here I take a look into this receptor agonist and antagonist discovery
Upregulating G Protein-Coupled Receptors with Receptor Antagonists
. This chapter reviews data that support antagonist-induced upregulation specifically of opioid receptors but many of the principles apply to other GPCRs as well. It is well documented that chronic exposure to opioid receptor antagonists
were found to be nonselective, and it was hoped that “specific antagonists” would be developed for analyzing the effects of indolealkylamines in various organisms (Gyermek, 1966).
技术资料暂无技术资料 索取技术资料
